string: Few SAEs were observed, reflecting previous data indicating that SAEs resulting from statin treatment are rare.(29) As the largest study to date focusing on statin therapy solely in patients with the metabolic syndrome, COMETS supports the good safety profile of rosuvastatin and atorvastatin reported previously by two post hoc subgroup analyses.